| 000 | 01745 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250516210200.0 | ||
| 264 | 0 | _c20150209 | |
| 008 | 201502s 0 0 eng d | ||
| 022 | _a1533-712X | ||
| 024 | 7 |
_a10.1097/JCP.0000000000000120 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChan, Hung-Yu | |
| 245 | 0 | 0 |
_aA double-blind, randomized comparison study of efficacy and safety of intramuscular olanzapine and intramuscular haloperidol in patients with schizophrenia and acute agitated behavior. _h[electronic resource] |
| 260 |
_bJournal of clinical psychopharmacology _cJun 2014 |
||
| 300 |
_a355-8 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAcute Disease |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAntipsychotic Agents _xadverse effects |
| 650 | 0 | 4 |
_aBenzodiazepines _xadverse effects |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHaloperidol _xadverse effects |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInjections, Intramuscular |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aOlanzapine |
| 650 | 0 | 4 | _aPsychiatric Status Rating Scales |
| 650 | 0 | 4 |
_aPsychomotor Agitation _xdrug therapy |
| 650 | 0 | 4 |
_aSchizophrenia _xdrug therapy |
| 650 | 0 | 4 | _aTaiwan |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aRee, Shao-Chun | |
| 700 | 1 | _aSu, Lien-Wen | |
| 700 | 1 | _aChen, Jiann-Jyh | |
| 700 | 1 | _aChou, Sun-Yuan | |
| 700 | 1 | _aChen, Chih-Ken | |
| 700 | 1 | _aChen, Ying-Sheue | |
| 773 | 0 |
_tJournal of clinical psychopharmacology _gvol. 34 _gno. 3 _gp. 355-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/JCP.0000000000000120 _zAvailable from publisher's website |
| 999 |
_c23747844 _d23747844 |
||